The notices it replaced
- Reissues: PAR-21-166 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
- 2 steps back: PAR-18-530 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
- 3 steps back: PAR-15-075 Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)
Who won it before
111 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $64,328,274 in first-year total cost, median $594,720.
Most frequent study sections
- Special Emphasis Panel[ZRG1 SBIB-Q (57)]76
- Special Emphasis Panel[ZRG1 SBIB-D (57)]14
- Special Emphasis Panel[ZRG1 CTH-E (57)]12
- Special Emphasis Panel[ZRG1 SBIB-S (57)]3
- Special Emphasis Panel[ZRG1-SBIB-Q(57)R]3
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL7
- CASE WESTERN RESERVE UNIVERSITY4
- EMORY UNIVERSITY4
- JOHNS HOPKINS UNIVERSITY4
- STANFORD UNIVERSITY4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Molecular subtyping of brain tumors using a blood-based multiplexed assay1R01CA291826-01A1 · under PAR-21-166 | BALAJ, LEONORACARTER, BOB S | MASSACHUSETTS GENERAL HOSPITAL, MA | $678,228 | ZRG1 |
| 2025 | Develop a novel therapy with immuno- and onco-targeting dual efficacies to treat the triple negative breast cancer1R01CA288387-01A1 · under PAR-21-166 | FANG, DEYULIU, HUIPING | NORTHWESTERN UNIVERSITY, IL | $661,072 | ZRG1 |
| 2025 | Lung Cancer Immunotherapy using new generation of TCR-engineered CD4 + T cells1R01CA302874-01 · under PAR-21-166 | WANG, RONGFU | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $650,450 | ZRG1 |
| 2025 | Developing purinergic receptor inverse agonists for treating triple negative breast cancer1R01CA293672-01A1 · under PAR-21-166 | JIANG, JEAN XRIQUELME, MANUELYUAN, YAXIA | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $616,071 | ZRG1 |
| 2024 | Clinical translation of a NexGen platform for quantifying protein networks in human biospecimens2R01CA235575-07 · under PAR-21-166 | PAULOVICH, AMANDA G | FRED HUTCHINSON CANCER CENTER, WA | $837,288 | ZRG1 |
| 2024 | Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells1R01CA292019-01 · under PAR-21-166 | MAGBANUA, MARK JESUSMASAELI, MAHDOKHTROSENBLUTH, JENNIFER M. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $679,188 | ZRG1 |
| 2024 | Enabling translation of cancer cell proliferation PET imaging via droplet radiochemistry technology1R01CA281901-01A1 · under PAR-21-166 | CHEN, KAIJONES, JASONVAN DAM, ROBERT MICHAEL | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $656,181 | ZRG1 |
| 2024 | Translating glycans into biomarkers1R01CA285370-01A1 · under PAR-21-166 | MEHTA, ANAND S. | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $596,254 | ZRG1 |
| 2024 | Real time scattered x-ray imaging for tumor motion tracking in radiotherapy.1R01CA285379-01A1 · under PAR-21-166 | JIA, XUNYANG, KAI | JOHNS HOPKINS UNIVERSITY, MD | $590,726 | ZRG1 |
| 2024 | A Real-Time Hyperspectral Laparoscopic Stereo Imaging System for Robot-Assisted Surgery1R01CA288379-01 · under PAR-21-166 | FEI, BAOWEI | UNIVERSITY OF TEXAS DALLAS, TX | $589,457 | ZRG1 |
| 2024 | Development of a Bioengineered Therapeutic Device for the Prevention of Lymphedema1R01CA285372-01A1 · under PAR-21-166 | HUANG, NGAN F.PAUKSHTO, MICHAEL VITOLDOVICH | PALO ALTO VETERANS INSTIT FOR RESEARCH, CA | $556,684 | ZRG1 |
| 2024 | A compact beam delivery system enabling ultra-fast dose delivery for upright proton therapy1R37CA288343-01 · under PAR-21-166 | NESTERUK, KONRAD PAWEL | MASSACHUSETTS GENERAL HOSPITAL, MA | $499,840 | ZRG1 |
| 2023 | Reflectance confocal microscopy-optical coherence tomography (RCM-OCT) imaging of oral lesions: Toward an affordable device and approach for developing countries1R01CA275789-01A1 · under PAR-21-166 | CHATURVEDI, PANKAJFOX, WILLIAM J.IFTIMIA, NICUSORRAJADHYAKSHA, MILIND | SLOAN-KETTERING INST CAN RESEARCH, NY | $728,739 | ZRG1 |
| 2023 | Therapeutic Targeting a Non-Hodgkin Lymphoma Driver Using AI1R01CA271546-01A1 · under PAR-21-166 | LI, YONG | BAYLOR COLLEGE OF MEDICINE, TX | $656,085 | ZRG1 |
| 2023 | EPR scanner for tumor oximetry in the clinic1R01CA269234-01A1 · under PAR-21-166 | KUPPUSAMY, PERIANNAN | DARTMOUTH COLLEGE, NH | $626,734 | ZRG1 |
| 2023 | 3-dimensional prompt gamma imaging for online proton beam dose verification1R01CA279013-01 · under PAR-21-166 | POLF, JERIMY C.REN, LEI | UNIVERSITY OF MARYLAND BALTIMORE, MD | $575,694 | ZRG1 |
| 2023 | Development of AI-Augmented quality assurance tools for radiation therapy1R01CA275772-01 · under PAR-21-166 | XING, LEI | STANFORD UNIVERSITY, CA | $550,091 | ZRG1 |
| 2023 | Ultra-High Performance Brain-dedicated PET scanner for Neurology and Neuro-oncology imaging1R01CA275942-01A1 · under PAR-21-166 | GONZALEZ MARTINEZ, ANTONIONEHMEH, SADEK | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $542,685 | ZRG1 |
| 2022 | Portable, Low Field Brain Magnetic Resonance Imaging (MRI) for Acute Stroke1R01EB031114-01A1 · under PAR-18-530 | KIMBERLY, WILLIAM TAYLORROSEN, MATTHEW SCOTSHETH, KEVIN NAVIN | YALE UNIVERSITY, CT | $744,150 | ZRG1 |
| 2022 | A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies1R01CA265928-01 · under PAR-18-530 | REINHERZ, ELLIS L | DANA-FARBER CANCER INST, MA | $713,250 | ZRG1 |
| 2022 | Novel targeted therapy for treating Ovarian Cancer1R01CA266970-01A1 · under PAR-21-166 | NAIR, HAREESH BABUVADLAMUDI, RATNA K | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $689,000 | ZRG1 |
| 2022 | Validation of a novel 3D culture platform for TNBC treatment selection1R01CA271682-01A1 · under PAR-21-166 | GALLUP, DAVIDUENO, NAOTO T.YUN, KYUSON | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $644,226 | ZRG1 |
| 2022 | Academic Industrial Partnership on Advanced Perfusion MRI1R01EB031080-01A1 · under PAR-18-530 | CHANG, YULIN VDETRE, JOHN AWANG, ZE | UNIVERSITY OF PENNSYLVANIA, PA | $607,329 | ZRG1 |
| 2022 | Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)1R01CA266059-01 · under PAR-18-530 | CREMER, MIRIAM | CLEVELAND CLINIC LERNER COM-CWRU, OH | $578,801 | ZRG1 |
| 2022 | WIRELESS MAGNETO-MECHANICAL CONTROL OF NEURAL ACTIVITY MEDIATED BY MAGNETIC NANODISCS1R56EB031848-01A1 · under PAR-21-166 | ROMERO URIBE, GABRIELA | UNIVERSITY OF TEXAS SAN ANTONIO, TX | $530,817 | ZRG1 |
| 2022 | Academic-Industrial Partnership to Develop Clinical Tools for Algorithmic Irreversible Electroporation of Inoperable Tumors1R01CA272550-01 · under PAR-21-166 | SANO, MICHAEL BENJAMIN | NORTH CAROLINA STATE UNIVERSITY RALEIGH, NC | $525,365 | ZRG1 |
| 2022 | Clinical Translation of Stimulated Raman Histology2R01CA226527-05 · under PAR-21-166 | ORRINGER, DANIEL | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $492,852 | ZRG1 |
| 2022 | A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain1R01CA258788-01A1 · under PAR-18-530 | ELSINGER, CATHERINE LLIU, HO-LING ANTHONY | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $402,421 | ZRG1 |
| 2022 | Automated interactive definition of the clinical target volume in radiation oncology1R01CA266275-01 · under PAR-18-530 | BORTFELD, THOMAS R. | MASSACHUSETTS GENERAL HOSPITAL, MA | $329,887 | ZRG1 |
| 2022 | Markerless Motion Tracking of Lung Tumors using Dual Energy Imaging2R01CA207483-04A1 · under PAR-18-530 | LEHMANN, MATHIASROESKE, JOHN | LOYOLA UNIVERSITY CHICAGO, IL | $318,295 | ZRG1 |
| 2021 | The UroMonitor: Innovative Technology to Improve Management of Bladder Dysfunction1R56EB031042-01 · under PAR-18-530 | DAMASER, MARGOT S. | CLEVELAND CLINIC LERNER COM-CWRU, OH | $948,822 | ZRG1 |
| 2021 | Real-time spectroscopic photoacoustic/ultrasound (PAUS) scanner withsimultaneous fluence and motion compensation to guide and validateinterventions: system development and preclinical testing.1R01EB030484-01A1 · under PAR-18-530 | O'DONNELL, MATTHEW | UNIVERSITY OF WASHINGTON, WA | $747,636 | ZRG1 |
| 2021 | Multimodal Intraoral Imaging System for Oral Cancer Detection and Diagnosis in Low Resource Setting1R01DE030682-01 · under PAR-18-530 | LIANG, RONGGUANG | UNIVERSITY OF ARIZONA, AZ | $693,571 | ZRG1 |
| 2021 | Three-Dimensional Multi-Parametric Ultrasound for Monitoring Therapy of Liver Metastasis2R01CA195443-04 · under PAR-18-530 | EL KAFFAS, AHMED | STANFORD UNIVERSITY, CA | $693,277 | ZRG1 |
| 2021 | Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI1R01CA255434-01A1 · under PAR-18-530 | KADLECEK, STEPHEN JRUSET, IULIAN CONSTANTIN | XEMED, LLC, NH | $662,399 | ZRG1 |
| 2021 | Personalized Motion Management for Truly 4D Lung Radiotherapy1R01CA262017-01 · under PAR-18-530 | GULLAPALLI, RAO PSAWANT, AMIT | UNIVERSITY OF MARYLAND BALTIMORE, MD | $658,497 | ZRG1 |
| 2021 | Biopsy Tract Sealing Device with Magnetic Resonance and X-Ray Image Contrast1R01CA254964-01 · under PAR-18-530 | MAITLAND, DUNCAN J | TEXAS ENGINEERING EXPERIMENT STATION, TX | $639,391 | ZRG1 |
| 2021 | Fluorescence Lifetime Imaging/Spectroscopy System For Robotic Cancer Surgery Guidance2R01CA187427-07 · under PAR-18-530 | FARWELL, DONALD GREGORYMARCU, LAURASORGER, JONATHAN M. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $633,669 | ZRG1 |
| 2021 | Human-like automated radiotherapy treatment planning via imitation learning1R01CA254377-01A1 · under PAR-18-530 | JIA, XUNJIANG, STEVE BINNGUYEN, DAN | UT SOUTHWESTERN MEDICAL CENTER, TX | $626,797 | ZRG1 |
| 2021 | Advancing molecular fluorescence-guided surgery platform2R01CA167413-06 · under PAR-18-530 | PAULSEN, KEITH D.SAMKOE, KIMBERLEY | DARTMOUTH COLLEGE, NH | $612,175 | ZRG1 |
| 2021 | Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI1R01CA241159-01A1 · under PAR-18-530 | METZGER, GREGORY JOHN | UNIVERSITY OF MINNESOTA, MN | $598,014 | ZRG1 |
| 2021 | Development of a Phenotype-based Predictive Analytic for Acute Myeloid Leukemia1R01CA262287-01 · under PAR-18-530 | MARK, TOMER MSAVONA, MICHAEL RWAGNER, JOSEPH P | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $597,007 | ZRG1 |
| 2021 | A transformative drug discovery platform for allosteric kinase inhibitors1R01CA255513-01 · under PAR-18-530 | LEVINSON, NICHOLAS MARKTHOMAS, DAVID D | UNIVERSITY OF MINNESOTA, MN | $596,314 | ZRG1 |
| 2021 | Development of an ultra-high dose rate rotational linac for FLASH Radiotherapy1R01CA255432-01 · under PAR-18-530 | BOUCHER, SALIMESHENG, KE | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $594,720 | ZRG1 |
| 2021 | An ultra-high (FLASH) dose rate x-ray cabinet system for pre-clinical laboratory radiation research1R01CA262097-01 · under PAR-18-530 | REZAEE, MOHAMMAD | JOHNS HOPKINS UNIVERSITY, MD | $576,386 | ZRG1 |
| 2021 | Development of next generation 2HG and metabolic MR imaging for precision oncology of mutant IDH and wildtype glioma patients1R01CA255479-01 · under PAR-18-530 | ANDRONESI, OVIDIU C | MASSACHUSETTS GENERAL HOSPITAL, MA | $569,946 | ZRG1 |
| 2021 | Imaging Goggles for Fluorescence-Guided Surgery1R01EB030987-01A1 · under PAR-18-530 | ACHILEFU, SAMUELBURAS, WILLIAM ROBINSON | WASHINGTON UNIVERSITY, MO | $564,129 | ZRG1 |
| 2021 | Preclinical Electron Paramagnetic Resonance Tumor Imager1R01CA262159-01 · under PAR-18-530 | EATON, GARETH R | UNIVERSITY OF DENVER (COLORADO SEMINARY), CO | $539,291 | ZRG1 |
| 2020 | Molecular Photoacoustic Imaging for Diagnostics and Therapy Monitoring1R01EB028762-01 · under PAR-18-530 | BOUCHARD, RICHARD R. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $649,539 | ZRG1 |
| 2020 | Depleting exosomes to improve responses to immune therapy in HNSCC1U01DE029759-01 · under PAR-18-530 | MARLEAU, ANNETTEWHITESIDE, THERESA L. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $627,000 | ZRG1 |
| 2020 | Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer1R01CA251911-01 · under PAR-18-530 | RICHARDS-KORTUM, REBECCA R.SCHMELER, KATHLEEN | RICE UNIVERSITY, TX | $614,528 | ZRG1 |
| 2020 | In vivo dual-axis confocal microscopy of 5-ALA-induced PpIX to guide low-grade glioma resections1R01CA244170-01 · under PAR-18-530 | LIU, JONATHAN T.C.SANAI, NADER | UNIVERSITY OF WASHINGTON, WA | $607,334 | ZRG1 |
| 2020 | Novel IL-12 Gene Delivery Vehicles for Transformation of Solid Tumors1R01CA244872-01 · under PAR-18-530 | POLLACK, SETH M | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $584,926 | ZRG1 |
| 2020 | Point-of-care cellular and molecular pathology of breast tumors on a cell phone1R01CA248491-01 · under PAR-18-530 | CHILKOTI, ASHUTOSHHWANG, E.SHELLEY | DUKE UNIVERSITY, NC | $581,490 | ZRG1 |
| 2020 | In situ PEDSy and light delivery platform for Intracavitory Photodynamic Therapy1R01EB028778-01A1 · under PAR-18-530 | POTASEK, MARYZHU, TIMOTHY C. | UNIVERSITY OF PENNSYLVANIA, PA | $576,523 | ZRG1 |
| 2020 | Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement1R01CA237005-01A1 · under PAR-18-530 | VISWANATHAN, AKILA | JOHNS HOPKINS UNIVERSITY, MD | $556,695 | ZRG1 |
| 2020 | Achieving Optimal Motor Function in Stroke Survivors via a Human-Centered Approach to Design an mHealth Platform1R01EB027777-01A1 · under PAR-18-530 | LEE, SUNGHOON | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $537,650 | ZRG1 |
| 2020 | Development of a multi-omic clinical decision platform to guide personalized therapy1R01CA244899-01A1 · under PAR-18-530 | PAREKH, SAMIR | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $519,735 | ZRG1 |
| 2020 | Robot-Assisted 3D ICE Catheter for Cardiac Ablation1R01EB028278-01A1 · under PAR-18-530 | JAGADEESAN, JAYENDER | BRIGHAM AND WOMEN'S HOSPITAL, MA | $437,331 | ZRG1 |
| 2020 | Boron Nitride Nanosheets to Enhance Dental Composite Performance1R56DE029457-01 · under PAR-18-530 | WHANG, KYUMIN | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $427,105 | ZRG1 |
| 2020 | Detecting DICER1: A global partnership to cure pediatric lung cancer1R37CA244940-01 · under PAR-18-530 | SCHULTZ, KRIS ANN PINEKENSTEIN | CHILDREN'S HOSPITALS AND CLINICS, MN | $411,901 | ZRG1 |
| 2020 | Coronary Fractional Flow Reserve Determined Using MRI and CFD1R01EB027774-01A1 · under PAR-18-530 | OSHINSKI, JOHN N | EMORY UNIVERSITY, GA | $354,663 | ZRG1 |
| 2019 | Clinical translation of a NexGen platform for quantifying protein networks in human biospecimens1R01CA235575-01A1 · under PAR-18-530 | PAULOVICH, AMANDA G | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $737,466 | ZRG1 |
| 2019 | Lymph Node Quantification System for Multisite Clinical Trials1R01CA235589-01A1 · under PAR-18-530 | HARRIS, GORDON JKIKINIS, RON | BRIGHAM AND WOMEN'S HOSPITAL, MA | $683,973 | ZRG1 |
| 2019 | Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapy1R01CA231606-01A1 · under PAR-18-530 | HASAN, TAYYABA | MASSACHUSETTS GENERAL HOSPITAL, MA | $646,771 | ZRG1 |
| 2019 | Translation of a biomarker panel for the early detection of hepatocellular carcinoma1R01CA237659-01 · under PAR-18-530 | MARRERO, JORGE AMEHTA, ANAND S. | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $546,516 | ZRG1 |
| 2019 | Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy1R37CA240806-01A1 · under PAR-18-530 | CHEN, YONGXIANG, LIANGZHONG SHAWN | UNIVERSITY OF OKLAHOMA, OK | $452,783 | ZRG1 |
| 2019 | Anatomical Modeling to Improve the Precision of Image Guided Liver Ablation1R01CA235564-01A1 · under PAR-18-530 | BROCK, KRISTYODISIO, BRUNO C | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $362,435 | ZRG1 |
| 2018 | Multimodal MR-PET Machine Learning Approaches for Primary Prostate Cancer Characterization1R01CA218187-01A1 · under PAR-15-075 | CATANA, CIPRIAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $684,119 | ZRG1 |
| 2018 | Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal Carcinoma1R01CA220581-01A1 · under PAR-15-075 | LEWIS, JAMESMADABHUSHI, ANANT | CASE WESTERN RESERVE UNIVERSITY, OH | $671,111 | ZRG1 |
| 2018 | Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers1R01CA216579-01A1 · under PAR-15-075 | MADABHUSHI, ANANTVELCHETI, VAMSIDHAR | CASE WESTERN RESERVE UNIVERSITY, OH | $670,734 | ZRG1 |
| 2018 | Comparison of cervical intraepithelial neoplasia 2/3 treatment outcomes with a portable LMIC-adapted thermal ablation device vs. gas-based cryotherapy1R01CA218195-01A1 · under PAR-15-075 | CREMER, MIRIAM | CLEVELAND CLINIC LERNER COM-CWRU, OH | $669,209 | ZRG1 |
| 2018 | An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.1R01CA214428-01A1 · under PAR-15-075 | KEMP, CHRISTOPHER J | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $647,099 | ZRG1 |
| 2018 | Translating buccal nanocytology for lung cancer screening into clinical practice1R01CA225002-01A1 · under PAR-15-075 | BACKMAN, VADIMROY, HEMANT K.SUBRAMANIAN, HARIHARAN | NORTHWESTERN UNIVERSITY, IL | $638,469 | ZRG1 |
| 2018 | Molecular Digital CytoImaging for Leukemia Drug Screening1R01CA222095-01A1 · under PAR-15-075 | MARTIN, JODYVU, TOTHU Q | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $605,517 | ZRG1 |
| 2018 | Clinical platform for high-throughput analyses of extracellular vesicles1R01CA229777-01 · under PAR-15-075 | LEE, HAKHOSKOG, JOHAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $597,308 | ZRG1 |
| 2018 | Sharpening the edge in pencil-beam proton therapy: an aftermarket collimation system to better spare normal tissue during radiation treatment1R37CA226518-01A1 · under PAR-15-075 | HYER, DANIEL ELLIS | UNIVERSITY OF IOWA, IA | $589,726 | ZRG1 |
| 2018 | Academic-Industry Partnership for the Translation of a Novel Optical Imaging Approach to guide Endocrine Cancer Surgery1R01CA212147-01A1 · under PAR-15-075 | MAHADEVAN-JANSEN, ANITA | VANDERBILT UNIVERSITY, TN | $563,912 | ZRG1 |
| 2018 | Next generation small animal radiation research platform1R37CA214639-01A1 · under PAR-15-075 | JIA, XUN | UT SOUTHWESTERN MEDICAL CENTER, TX | $545,755 | ZRG1 |
| 2018 | Clinical Translation of Stimulated Raman Histology1R01CA226527-01 · under PAR-15-075 | ORRINGER, DANIEL | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $529,945 | ZRG1 |
| 2018 | Radioluminescence dosimetry solution for precision radiation therapy1R01CA223667-01A1 · under PAR-15-075 | XING, LEI | STANFORD UNIVERSITY, CA | $521,555 | ZRG1 |
| 2018 | Molecular complete response in blood as a predictor for pathologic complete response after neoadjuvant therapy for breast cancer1R01CA214494-01A1 · under PAR-15-075 | PARK, BEN HO | JOHNS HOPKINS UNIVERSITY, MD | $224,662 | ZRG1 |
| 2017 | CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING1R01CA214554-01 · under PAR-15-075 | FERRONE, MARCUSHURD, RALPH EUGENEKURHANEWICZ, JOHN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $684,591 | ZRG1 |
| 2017 | Large aperture and wideband modular ultrasound arrays for the diagnosis of liver cancer1R01CA211602-01A1 · under PAR-15-075 | FERRARA, KATHERINE WTRAHEY, GREGG E.ZHOU, QIFA | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $667,368 | ZRG1 |
| 2017 | A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors1R01CA217956-01 · under PAR-15-075 | BRADY-KALNAY, SUSANN MGASTINEAU, EDWARDSLOAN, ANDREW E | CASE WESTERN RESERVE UNIVERSITY, OH | $662,909 | ZRG1 |
| 2017 | Focal Laser Ablation of Prostate Cancer using MR/US Fusion1R01CA218547-01 · under PAR-15-075 | HU, JIMMARKS, LEONARD STEPHENNATARAJAN, SHYAMSONN, GEOFFREY | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $627,518 | ZRG1 |
| 2017 | A blood test to identify prostate cancer patients at risk for visceral metastasis1R01CA218356-01 · under PAR-15-075 | POSADAS, EDWIN MELENCIOTSENG, HSIAN-RONG | CEDARS-SINAI MEDICAL CENTER, CA | $620,500 | ZRG1 |
| 2017 | Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer1R01CA206584-01A1 · under PAR-15-075 | GOODISON, STEVE | MAYO CLINIC JACKSONVILLE, FL | $618,256 | ZRG1 |
| 2017 | Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer1R01CA211939-01A1 · under PAR-15-075 | HAYES, DAVID NZEVALLOS, JOSE P. | WASHINGTON UNIVERSITY, MO | $615,138 | ZRG1 |
| 2017 | A novel point of care test for oral and oropharyngeal cancer risk1R01CA204264-01A1 · under PAR-15-075 | CALIFANO, JOSEPH AFRANZMANN, ELIZABETH J | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $593,922 | ZRG1 |
| 2017 | Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force2R01CA142824-06A1 · under PAR-15-075 | NIGHTINGALE, KATHRYN RADABAUGH | DUKE UNIVERSITY, NC | $546,174 | ZRG1 |
| 2017 | Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells2R01CA134633-05 · under PAR-15-075 | AHRENS, ERIC T.COHEN, EZRA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $540,493 | ZRG1 |
| 2017 | Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again1R01CA216879-01 · under PAR-15-075 | KELLY, KIMBERLY A.SUTCLIFFE, JULIE L | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $524,668 | ZRG1 |
| 2017 | Automated Volumetric Molecular Ultrasound for Breast Cancer Imaging1R01CA218204-01 · under PAR-15-075 | DAHL, JEREMYDANIEL, BRUCE LDEMARTINI, WENDY | STANFORD UNIVERSITY, CA | $477,755 | ZRG1 |
| 2017 | 2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma1R01CA203388-01A1 · under PAR-15-075 | MAO, HUIZHONG, XIAODONG | EMORY UNIVERSITY, GA | $427,689 | ZRG1 |
| 2017 | Markerless Motion Tracking of Lung Tumors Using Dual Energy Imaging1R01CA207483-01A1 · under PAR-15-075 | MOSTAFAVI, HASSANROESKE, JOHN | LOYOLA UNIVERSITY CHICAGO, IL | $385,045 | ZRG1 |
| 2017 | Improving the in vivo delivery and antitumor efficacy of antisense drugs1R01CA214550-01 · under PAR-15-075 | PANG, HONGBO | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $110,639 | ZRG1 |
| 2016 | Transforming the diagnosis and care of patients with CTCL using TCR sequencing1R01CA203721-01 · under PAR-15-075 | CLARK, RACHAEL ANNKUPPER, THOMAS S. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $742,632 | ZRG1 |
| 2016 | Computerized histologic image predictor of cancer outcome1R01CA202752-01A1 · under PAR-15-075 | FELDMAN, MICHAEL DGANESAN, SHRIDARMADABHUSHI, ANANT | CASE WESTERN RESERVE UNIVERSITY, OH | $699,670 | ZRG1 |
| 2016 | Development of novel selective Rac inhibitors for refractory leukemias1R01CA202756-01A1 · under PAR-15-075 | WILLIAMS, DAVID A | BOSTON CHILDREN'S HOSPITAL, MA | $638,223 | ZRG1 |
| 2016 | Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung SABR1R01CA202761-01A1 · under PAR-15-075 | SAWANT, AMITTIMMERMAN, ROBERT D | UNIVERSITY OF MARYLAND BALTIMORE, MD | $608,909 | ZRG1 |
| 2016 | Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging1R01CA202695-01A1 · under PAR-15-075 | GREEN, MARK AHUTCHINS, GARY D | INDIANA UNIVERSITY INDIANAPOLIS, IN | $591,408 | ZRG1 |
| 2016 | Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer1R01CA202762-01A1 · under PAR-15-075 | RICIGLIANO, MARKYU, KENNETH H. | SLOAN-KETTERING INST CAN RESEARCH, NY | $575,993 | ZRG1 |
| 2016 | Biomarkers of Molecular Age to Predict the Toxicity of Cancer Chemotherapy1R01CA203023-01 · under PAR-15-075 | ELAM, AMANDAMITIN, NATALIAMUSS, HYMANSHARPLESS, NORMAN E | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $572,222 | ZRG1 |
| 2016 | Integrated Discovery Pipeline for Tumor Neoantigens1R01CA204261-01A1 · under PAR-15-075 | CARRENO, BEATRIZ M.LINETTE, GERALD P | UNIVERSITY OF PENNSYLVANIA, PA | $562,825 | ZRG1 |
| 2016 | Real-time monitoring of circulating pancreatic tumor cells and clusters1R01CA207643-01 · under PAR-15-075 | CARPENTER, ERICA | UNIVERSITY OF PENNSYLVANIA, PA | $544,582 | ZRG1 |
| 2016 | Membrane-based immunotherapy for triple negative breast cancer- a partnered approach1R01CA202763-01A1 · under PAR-15-075 | PACK, CHRISTOPHER DSELVARAJ, PERIASAMY | EMORY UNIVERSITY, GA | $502,655 | ZRG1 |
| 2016 | A partnership to enable clinical ctDNA testing for breast cancer recurrence1R01CA204253-01 · under PAR-15-075 | VARLEY, KATHERINE ELENA | UNIVERSITY OF UTAH, UT | $481,993 | ZRG1 |
| 2016 | Development of cell-free DNA assays for HCC screening and liquid biopsy1R01CA202769-01 · under PAR-15-075 | SU, YING-HSIU | BARUCH S. BLUMBERG INSTITUTE, PA | $432,900 | ZRG1 |
| 2016 | Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles1R01CA202846-01 · under PAR-15-075 | MAO, HUIWANG, YONGQIANG ANDREWYANG, LILY | EMORY UNIVERSITY, GA | $425,268 | ZRG1 |
| 2016 | Development of Anatomical Patient Models to Facilitate MR-only Treatment Planning1R01CA204189-01A1 · under PAR-15-075 | GLIDE-HURST, CARRI KAYE | HENRY FORD HEALTH SYSTEM, MI | $350,943 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.